FNArena Windows
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
| ASX CODE | LAST PRICE | % MOVE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET | UPSIDE/DOWNSIDE |
|---|---|---|---|---|---|---|---|
| 4DX | $1.58 |
|
$2.55 | $0.23 |
$2.075 |
|
|
| AT1 | $0.03 | 0.00% | $0.03 | $0.01 |
|
||
| AYA | $3.03 |
|
$4.02 | $0.42 |
|
||
| BB1 | $0.81 |
|
$0.83 | $0.24 |
|
||
| BRN | $0.17 | 0.00% | $0.45 | $0.17 |
|
||
| CAT | $5.04 |
|
$7.72 | $2.98 | -41.1 |
$6.567 |
|
| CBL | $0.07 |
|
$0.09 | $0.03 |
|
||
| CGS | $2.60 |
|
$2.97 | $0.96 |
|
||
| CMP | $0.33 |
|
$0.42 | $0.24 |
|
||
| COH | $275.98 |
|
$323.00 | $246.14 | 39.7 |
$306.74 |
|
| CSX | $0.65 |
|
$0.88 | $0.31 |
|
||
| CU6 | $3.51 |
|
$6.44 | $1.43 |
$6.40 |
|
|
| CVB | $0.07 | 0.00% | $0.18 | $0.06 |
$0.15 |
|
|
| CYC | $0.68 |
|
$2.47 | $0.56 |
$1.50 |
|
|
| EBR | $1.04 |
|
$2.08 | $0.86 |
$2.645 |
|
|
| EMV | $1.82 |
|
$2.43 | $1.63 |
$3.15 |
|
|
| EYE | $0.13 |
|
$0.20 | $0.09 |
|
||
| FPH | $31.83 |
|
$35.75 | $29.08 | 49.0 |
|
|
| IME | $0.32 |
|
$0.45 | $0.22 |
$0.35 |
|
|
| IMR | $1.39 |
|
$1.86 | $0.93 |
$2.22 |
|
|
| IPD | $0.04 |
|
$0.06 | $0.03 |
$0.125 |
|
|
| LDX | $0.22 |
|
$0.28 | $0.02 |
|
||
| MX1 | $0.08 |
|
$0.12 | $0.04 |
$0.17 |
|
|
| NAN | $4.14 |
|
$5.18 | $2.88 | 61.0 |
$4.55 |
|
| ONE | $0.31 |
|
$0.38 | $0.17 |
$0.25 |
|
|
| PCK | $0.04 |
|
$0.11 | $0.02 |
|
||
| PEB | $0.15 | 0.00% | $0.19 | $0.05 |
|
||
| PGC | $0.30 |
|
$0.59 | $0.24 | 14.3 |
$0.495 |
|
| PME | $260.09 |
|
$336.00 | $161.64 | 174.0 |
$322.767 |
|
| RMD | $38.52 |
|
$45.25 | $32.04 | 22.2 |
$49.01 |
|
| SOM | $0.79 |
|
$0.95 | $0.36 | 49.4 |
$0.99 |
|
| TRJ | $0.67 |
|
$1.14 | $0.63 | 22.0 |
$1.25 |
|
2.60% 
Previous Stories
Dr Boreham’s Crucible: Imagion Biosystems
Feb 13 2023
Tim Boreham reports Imagion’s CEO believes the oncology imaging innovator has achieved far more with its initial early-stage breast cancer study results than investors might appreciate.
ResMed: Philips Remains The Big Unknown
Jan 31 2023
Lack of competition, alongside improved component supply, sees ResMed deliver a strong second quarter
Nanosonics Outlook Remains Clouded
Jan 24 2023
Following a change to a direct distribution model, Nanosonics has delivered a better than expected first half, but brokers remain cautious
Nanosonics Recovers On Less Negative Sentiment
Nov 29 2022
A turn in sentiment has allowed Nanosonics shares to recover, with (some) broker views turning less negative
Treasure Chest: Fisher & Paykel Healthcare
Nov 16 2022
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Fisher & Paykel Healthcare
Dr Boreham’s Crucible: Imricor Medical Systems
Oct 17 2022
Imricor is a player in a global catheter ablation market worth $US5.5 billion and growing at a compound rate of just over 8% a year
Market Share Gains Key to ResMed’s Outlook
Aug 15 2022
Following FY22 results, brokers set higher price targets for ResMed on average and expect market share gains
Dr Boreham’s Crucible: 4D Medical
Aug 08 2022
Dedicated lung imaging pioneer 4D medical sees itself as a software company, with lots of future potential, including from the US military
Latest News
| 1 |
ASX Winners And Losers Of Today – 25-11-25Nov 25 2025 - Daily Market Reports |
| 2 |
Picking A Lane: Car Platform Carma’s ASX ListingNov 25 2025 - Small Caps |
| 3 |
Weekly Update On LICs & LITs – 25-Nov-2025Nov 25 2025 - Weekly Reports |
| 4 |
4DMedical Poised For A RecoveryNov 25 2025 - Technicals |
| 5 |
Nufarm’s Growing OptimismNov 25 2025 - Small Caps |